A current update on the rule of alternative and complementary medicine in the treatment of liver diseases

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Guan, Yong Song ^a   He, Qing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AZATHIOPRINE; BILE ACID; BUDESONIDE; CARBOHYDRATE; CHINESE DRUG; COPPER; CURCUMIN; EMODIN; PARACETAMOL; PHOSPHOLIPID; PREDNISONE; PROBIOTIC AGENT; QUERCETIN; SALICYLIC ACID DERIVATIVE; SILYMARIN;

ADD ON THERAPY; ALAGILLE SYNDROME; ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ALTERNATIVE MEDICINE; AUTOIMMUNE LIVER DISEASE; CHINESE MEDICINE; CHRONIC HEPATITIS; DISEASE EXACERBATION; DRUG MEGADOSE; FEVER; GALACTOSEMIA; GLYCOGEN STORAGE DISEASE TYPE 1; HEPATIC PORPHYRIA; HEPATITIS; HEPATITIS C; HUMAN; IDIOPATHIC DISEASE; INFECTIOUS HEPATITIS; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER TOXICITY; MALNUTRITION; NONALCOHOLIC FATTY LIVER; PAIN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STEATOSIS; SUPPLEMENTATION; TYROSINEMIA; WILSON DISEASE;

EID: 84885413444     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/321234     Document Type: Review

References (115)

1. Shen X.-D., Ke B., Zhai Y., Gao F., Tsuchihashi S.-I., Lassman C. R., Busuttil R. W., Kupiec-Weglinski J. W., Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model. Liver Transplantation 2007 13 10 1435 1443 2-s2.0-35448988443 10.1002/lt.21251 (Pubitemid 47629578)
2. Lata J., Chronic liver diseases as liver tumor precursors. Digestive Diseases 2010 28 4-5 596 599 2-s2.0-78649373417 10.1159/000320057
3. Baffy G., Brunt E. M., Caldwell S. H., Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. Journal of Hepatology 2012 56 6 1384 1391 2-s2.0-84858167155 10.1016/j.jhep.2011.10.027
4. Latt N., Alachkar N., Gurakar A., Hepatitis C virus and its renal manifestations: a review and update. Gastroenterology & Hepatology 2012 8 7 434 445
5. Basaranoglu M., Basaranoglu G., Sabuncu T., Sentürk H., Fructose as a key player in the development of fatty liver disease. World Journal of Gastroenterology 2013 19 8 1166 1172
6. Imani Fooladi A. A., Mahmoodzadeh Hosseini H., Nourani M. R., Khani S., Alavian S. M., Probiotic as a novel treatment strategy against liver disease. Hepatitis Monthly 2013 13 2 e7521
7. Asselah T., Lada O., Marcellin P., Treatment of chronic hepatitis B. Revue du Praticien 2011 61 1 45 51 2-s2.0-79851493355
8. Tolmane I., Rozentale B., Keiss J., Arsa F., Brigis G., Zvaigzne A., The prevalence of viral hepatitis C in Latvia: a population-based study. Medicina 2011 47 10 532 535 2-s2.0-84856680409
9. Schmucker D. L., Age-related changes in liver structure and function: implications for disease? Experimental Gerontology 2005 40 8-9 650 659 2-s2.0-24644438250 10.1016/j.exger.2005.06.009 (Pubitemid 41265815)
10. Lei P., Moeslein F., Wood B. J., Shekhar R., Real-time tracking of liver motion and deformation using a flexible needle. International Journal of Computer Assisted Radiology and Surgery 2011 6 3 435 446 2-s2.0-79956202019 10.1007/s11548-010-0523-7
11. Gatell J. M., When and why to start antiretroviral therapy? Journal of Antimicrobial Chemotherapy 2010 65 3 383 385 2-s2.0-77950326941 10.1093/jac/dkp487
12. Porceddu M., Buron N., Roussel C., Labbe G., Fromenty B., Borgne-Sanchez A., Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicological Sciences 2012 129 2 332 345
13. Al-Zahim A. A., Al-Malki N. Y., Al-Abdulkarim F. M., Al-Sofayan S. A., Abunab H. A., Abdo A. A., Use of alternative medicine by Saudi liver disease patients attending a tertiary care center: prevalence and attitudes. Saudi Journal of Gastroenterology 2013 19 2 75 80
14. McClain C. J., Barve S. S., Barve A., Marsano L., Alcoholic liver disease and malnutrition. Alcoholism 2011 35 5 815 820 2-s2.0-79955482669 10.1111/j.1530-0277.2010.01405.x
15. Singal A. K., Charlton M. R., Nutrition in alcoholic liver disease. Clinics in Liver Disease 2012 16 4 805 826
16. Della Corte C., Sartorelli M. R., Comparcola D., Autoimmune liver diseases. Minerva Pediatrica 2012 64 6 595 606
17. Snider K. R., Potter T. G., Budesonide for the treatment of autoimmune hepatitis. Annals of Pharmacotherapy 2011 45 9 1144 1150 2-s2.0-80052435492 10.1345/aph.1Q244
18. Gupta S. C., Kismali G., Aggarwal B. B., Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 2013 39 1 2 13
19. Kuo J. J., Chang H. H., Tsai T. H., Lee T. Y., Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis. International Journal of Molecular Medicine 2012 30 3 643 649
20. Vinod B. S., Maliekal T. T., Anto R. J., Phytochemicals as chemosensitizers: from molecular mechanism to clinical significance. Antioxidants & Redox Signaling 2013 18 11 1307 1348
21. Tesdal I. K., Wikström M., Flechtenmacher C., Filser T., Dueber C., Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts. CardioVascular and Interventional Radiology 2006 29 5 778 784 2-s2.0-33746458970 10.1007/s00270-005-0063-7 (Pubitemid 44128009)
22. Saad W. E., Darwish W. M., Davies M. G., Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. American Journal Roentgenology 2013 200 1 210 218
23. Bean P., The use of alternative medicine in the treatment of hepatitis C. American Clinical Laboratory 2002 21 4 19 21 2-s2.0-0036561695
24. Liu C., Sun M., Wang L., Wang G., Chen G., Liu C., Liu P., Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats. Chinese Medicine 2008 3, article 1 2-s2.0-41049090414 10.1186/1749-8546-3- 1
25. De Donato G., Setacci F., Sirignano P., Galzerano G., Raucci A., Palasciano G., Setacci C., Hybrid procedures for acute limb ischemia. Journal of Cardiovascular Surgery 2010 51 6 845 853 2-s2.0-79952060415
26. Van Der Laan L. J. W., Wang Y., Tilanus H. W., Janssen H. L. A., Pan Q., AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application? Expert Opinion on Biological Therapy 2011 11 3 315 327 2-s2.0-79851480011 10.1517/14712598.2011.548799
27. Wu Y., Shao Q., Zhen Z., Cheng Y., Determination of quinolizidine alkaloids in Sophora flavescens and its preparation using capillary electrophoresis. Biomedical Chromatography 2006 20 5 446 450 2-s2.0-33646774271 10.1002/bmc.581
28. Talwani R., Gilliam B. L., Howell C., Infectious diseases and the liver. Clinics in Liver Disease 2011 15 1 111 130 2-s2.0-78649508019 10.1016/j.cld.2010.09.002
29. Giorgio A., Calisti G., de Stefano G., Farella N., Scognamiglio U., Giorgio V., Percutaneous treatment of hydatid liver cysts: an update. Recent Patents on Anti-Infective Drug Discovery 2012 7 3 231 236
30. Heineman J., Bubenik S., McClave S., Martindale R., Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases? Current Gastroenterology Reports 2012 14 4 343 348
31. Polyak S. J., Morishima C., Lohmann V., Pal S., Lee D. Y. W., Liu Y., Graf T. N., Oberlies N. H., Identification of hepatoprotective flavonolignans from silymarin. Proceedings of the National Academy of Sciences of the United States of America 2010 107 13 5995 5999 2-s2.0-77950540443 10.1073/pnas. 0914009107
32. Li D., An D., Zhou Y., Liu J., Waalkes M. P., Current status and prevention strategy for coal-arsenic poisoning in Guizhou, China. Journal of Health, Population and Nutrition 2006 24 3 273 276 2-s2.0-33846480842 (Pubitemid 46455235)
33. Tournel G., Houssaye C., Humbert L., Dhorne C., Gnemmi V., Bécart-Robert A., Nisse P., Hédouin V., Gosset D., Lhermitte M., Acute arsenic poisoning: clinical, toxicological, histopathological, and forensic features. Journal of Forensic Sciences 2011 56 1 S275 S279 2-s2.0-78650747518 10.1111/j.1556-4029.2010.01581.x
34. Gundermann K.-J., Kuenker A., Kuntz E., Droździk M., Activity of essential phospholipids (EPL) from soybean in liver diseases. Pharmacological Reports 2011 63 3 643 659 2-s2.0-80051530692
35. Reid A. E., Nonalcoholic steatohepatitis. Gastroenterology 2001 121 3 710 723 2-s2.0-0034831067 (Pubitemid 32822586)
36. Wan X.-Y., Luo M., Li X.-D., He P., Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. Chemico-Biological Interactions 2009 181 1 15 19 2-s2.0-67650651929 10.1016/j.cbi.2009.04.013
37. Schieman C., Rudmik L. R., Dixon E., Sutherland F., Bathe O. F., Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients. Canadian Journal of Surgery 2009 52 5 422 426 2-s2.0-70350061275
38. Yin D. L., Jiang H. C., Liang Y. J., Precise hepatectomy guided by minimally invasive surgery: a novel strategy for liver resection. Hepatogastroenterology 2012 59 118 1951 1959
39. Ridruejo E., Castiglioni T., Silva M. O., Thioctic acid-induced acute cholestatic hepatitis. The Annals of Pharmacotherapy 2011 45 7-8, article e43 2-s2.0-84855752762
40. Trivedi P. J., Hirschfield G. M., Review article: overlap syndromes and autoimmune liver disease. Alimentary Pharmacology & Therapeutics 2012 36 6 517 533
41. Reddy S. K., Steel J. L., Chen H.-W., Demateo D. J., Cardinal J., Behari J., Humar A., Marsh J. W., Geller D. A., Tsung A., Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology 2012 55 6 1809 1819 2-s2.0-84859933579 10.1002/hep.25536
42. Iloeje U. H., Yang H.-I., Chen C.-J., Natural history of chronic hepatitis B: what exactly has REVEAL Revealed? Liver International 2012 32 9 1333 1341 2-s2.0-84859788461 10.1111/j.1478-3231.2012.02805.x
43. Teschke R., Schwarzenboeck A., Eickhoff A., Frenzel C., Wolff A., Schulze J., Clinical and causality assessment in herbal hepatotoxicity. Expert Opinion on Drug Safety 2013 12 3 339 366
44. Kudo M., Advances in liver fibrosis imaging and hepatocellular carcinoma: update in 2013. Preface. Oncology 2013 84 supplement 1 1 2
45. Suzuki A., Brunt E. M., Kleiner D. E., Miquel R., Smyrk T. C., Andrade R. J., Isabel Lucena M., Castiella A., Lindor K., Björnsson E., The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011 54 3 931 939 2-s2.0-80052023773 10.1002/hep.24481
46. Rahimi R. S., Rockey D. C., End-stage liver disease complications. Current Opinion in Gastroenterology 2013 29 3 257 263
47. Guérin F., Blanc T., Gauthier F., Abella S. F., Branchereau S., Congenital portosystemic vascular malformations. Seminars in Pediatric Surgery 2012 21 3 233 244
48. Olsson K. S., Wålinder O., Kindmark A., Williams R., Common local founder effects for Wilson's disease and hereditary hemochromatosis, mutation studies of a large family. Scandinavian Journal of Gastroenterology 2012 47 8-9 1014 1020
49. Lioy P. J., Fan Z., Zhang J., Georgopoulos P., Wang S.-W., Ohman-Strickland P., Wu X., Zhu X., Harrington J., Tang X., Meng Q., Jung K. H., Kwon J., Hernandez M., Bonnano L., Held J., Neal J., HEI Health Review Committee, Personal and ambient exposures to air toxics in Camden, New Jersey. Research Report 2011 160 3 151 2-s2.0-84856492295
50. Liu Y.-P., Ni Y.-H., Fang C.-C., Chen W.-J., Fulminant hepatic failure due to chronic acetaminophen intoxication in an infant. American Journal of Emergency Medicine 2005 23 1 94 95 2-s2.0-12744258020 10.1016/j.ajem.2003.12.030
51. Aerts J. M., Boot R. G., Van Eijk M., Groener J., Bijl N., Lombardo E., Bietrix F. M., Dekker N., Groen A. K., Ottenhoff R., Van Roomen C., Aten J., Serlie M., Langeveld M., Wennekes T., Overkleeft H. S., Glycosphingolipids and insulin resistance. Advances in Experimental Medicine and Biology 2011 721 99 119 2-s2.0-80053591938 10.1007/978-1-4614-0650-1-7
52. Brunt E. M., Pathology of nonalcoholic fatty liver disease. Nature Reviews Gastroenterology and Hepatology 2010 7 4 195 203 2-s2.0-77950858243 10.1038/nrgastro.2010.21
53. Cong W.-M., Dong H., Tan L., Sun X.-X., Wu M.-C., Surgicopathological classification of hepatic space-occupying lesions: a single-center experience with literature review. World Journal of Gastroenterology 2011 17 19 2372 2378 2-s2.0-79957801312 10.3748/wjg.v17.i19.2372
54. Yoshida E. M., Haque M., Scudamore C. H., Adult live donor liver transplantation: routine, commonplace, standard care for end stage liver disease (we hope). Annals of Hepatology 2010 9 1 89 90 2-s2.0-77954567942
55. Berle C. A., Cobbin D., Smith N., Zaslawski C., A novel approach to evaluate traditional Chinese medicine treatment outcomes using pattern identification. Journal of Alternative and Complementary Medicine 2010 16 4 357 367 2-s2.0-77951971266 10.1089/acm.2009.0367
56. Alqahtani S. A., Update in liver transplantation. Discovery Medicine 2012 14 75 133 141
57. Safdar Z., Bartolome S., Sussman N., Portopulmonary hypertension: an update. Liver Transplantation 2012 18 8 881 891
58. Shiffman M. L., Saab S., Feng S., Abecassis M. I., Tzakis A. G., Goodrich N. P., Schaubel D. E., Liver and intestine transplantation in the United States, 1995-2004. American Journal of Transplantation 2006 6 5 1170 1187 2-s2.0-33645693609 10.1111/j.1600-6143.2006.01273.x
59. Li M., Qiao C., Qin L., Zhang J., Ling C., Application of traditional Chinese medicine injection in treatment of primary liver cancer: a review. Journal of Traditional Chinese Medicine 2012 32 3 299 307
60. Bunchorntavakul C., Chavalitdhamrong D., Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. World Journal of Hepatology 2012 4 5 158 168
61. Subbarayappa B. V., The roots of ancient medicine: an historical outline. Journal of Biosciences 2001 26 2 135 143 2-s2.0-0034958362 (Pubitemid 32601707)
62. Wang X. B., Feng Y., Wang N., Cheung F., Wong C. W., Recent progress on anti-liver fibrosis candidates in patents of herbal medicinal products. Recent Patents on Food, Nutrition & Agriculture 2012 4 2 91 106
63. Jeong T. Y., Park B. K., Cho J. H., Kim Y. I., Ahn Y. C., Son C. G., A prospective study on the safety of herbal medicines, used alone or with conventionalmedicines. Journal of Ethnopharmacology 2012 143 3 884 888
64. Louhiala P., There is no alternative medicine. Medical Humanities 2010 36 2 115 117 2-s2.0-78650315063 10.1136/jmh.2010.004358
65. Renckens C. N. M., Alternative treatments in reproductive medicine: much ado about nothing: "The fact that millions of people do not master arithmetic does not prove that two times two is anything else than four": W.F.Hermans. Human Reproduction 2002 17 3 528 533 2-s2.0-0036125879 (Pubitemid 34232414)
66. Hu Y., Chen L., Shu J., Yao Y., Yan H. M., Clinical study on treatment of infantile cytomegalovirus hepatitis with integrated Chinese and Western medicine. Chinese Journal of Integrative Medicine 2012 18 2 100 105
67. Holmberg C., Brinkhaus B., Witt C., Experts' opinions on terminology for complementary and integrative medicine-a qualitative study with leading experts. BMC Complementary and Alternative Medicine 2012 12 218
68. Roberti di Sarsina P., Iseppato I., Why we need integrative medicine. EPMA Journal 2011 2 1 5 7 2-s2.0-79955674619 10.1007/s13167-011-0065-2
69. Waldman H. B., Cannella D., Perlman S. P., Do you consider complementary and alternative medicine in your medical history review? Journal of the Massachusetts Dental Society 2010 59 1 24 26 2-s2.0-77954901344
70. Chan E., Tan M., Xin J., Sudarsanam S., Johnson D. E., Interactions between traditional Chinese medicines and Western therapeutics. Current Opinion in Drug Discovery and Development 2010 13 1 50 65 2-s2.0-73849123558
71. Yu J.-Q., Bao W., Lei J.-C., Emodin regulates apoptotic pathway in human liver cancer cells. Phytotherapy Research 2013 27 2 251 257 2-s2.0-84860602430 10.1002/ptr.4703
72. Bass N. M., Is there any use for nontraditional or alternative therapies in patients with chronic liver disease? Current Gastroenterology Reports 1999 1 1 50 56 2-s2.0-0033068786
73. Fung M. C., Bowen D. L., Silver products for medical indications: risk-benefit assessment. Journal of Toxicology 1996 34 1 119 126 2-s2.0-0030051401 (Pubitemid 26060866)
74. Zhang J. M., Liao W., He Y. X., He Y., Yan D., Fu C. M., Study on intestinal absorption and pharmacokinetic characterization of diester diterpenoid alkaloids in precipitation derived from Fuzi-Gancao herb-pair decoction for its potential interaction mechanism investigation. Journal of Ethnopharmacology 2013 147 1 128 135
75. Zhang Y., Yao X., Suppressive effects of YiGanKang, a combination of Chinese herbs, on collagen synthesis in hepatic stellate cell. Journal of Ethnopharmacology 2011 134 3 949 952 2-s2.0-79954419999 10.1016/j.jep.2011.02. 014
76. Halberstein R. A., Medicinal plants: historical and cross-cultural usage patterns. Annals of Epidemiology 2005 15 9 686 699 2-s2.0-24644460504 10.1016/j.annepidem.2005.02.004 (Pubitemid 41266973)
77. Han W., He E., Cao J., Application of traditional Chinese medicine injections using traditional Chinese medicine theory. Zhongguo Zhong Yao Za Zhi 2012 37 16 2498 2500
78. Bate R., Jensen P., Hess K., Mooney L., Milligan J., Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. The International Journal of Tuberculosis and Lung Disease 2013 17 3 308 311
79. Sharma S., Injections-how safe. Journal of the Indian Medical Association 2005 103 4 210 211 2-s2.0-26944486307 (Pubitemid 41659589)
80. Peng X., Zhao Y., Liang X., Wu L., Cui S., Guo A., Wang W., Assessing the quality of RCTs on the effect of β -elemene, one ingredient of a Chinese herb, against malignant tumors. Contemporary Clinical Trials 2006 27 1 70 82 2-s2.0-28744441464 10.1016/j.cct.2005.07.002 (Pubitemid 41758440)
81. Wang H.-N., Chen W., Fu Z., Du W.-M., He J., Necesity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections. Zhongguo Zhongyao Zazhi 2008 33 5 612 614 2-s2.0-41749123418
82. Hadziyannis S. J., Milestones and perspectives in viral hepatitis B. Liver International 2011 31 1 129 134 2-s2.0-78650817009 10.1111/j.1478-3231. 2010.02406.x
83. Johnson D. E., Johnson K. A., Baldwin R. L., Changes in liver and gastrointestinal tract energy demands in response to physiological workload in ruminants. Journal of Nutrition 1990 120 6 649 655 2-s2.0-0025330946 (Pubitemid 20197973)
84. Doi H., Horie T., Salicylic acid-induced hepatotoxicity triggered by oxidative stress. Chemico-Biological Interactions 2010 183 3 363 368 2-s2.0-74149086075 10.1016/j.cbi.2009.11.024
85. Mahdi J. G., Mahdi A. J., Mahdi A. J., Bowen I. D., The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential. Cell Proliferation 2006 39 2 147 155 2-s2.0-33644954675 10.1111/j.1365-2184.2006.00377.x
86. Blande J. D., Korjus M., Holopainen J. K., Foliar methyl salicylate emissions indicate prolonged aphid infestation on silver birch and black alder. Tree Physiology 2010 30 3 404 416 2-s2.0-77649320453 10.1093/treephys/tpp124
87. Chang C.-C., Lin Y.-T., Lu Y.-T., Liu Y.-S., Liu J.-F., Kiwifruit improves bowel function in patients with irritable bowel syndrome with constipation. Asia Pacific Journal of Clinical Nutrition 2010 19 4 451 457 2-s2.0-78751556777
88. Vitaglione P., Fogliano V., Stingo S., Scalfi L., Capraso N., Morisco F., Development of a tomato-based food for special medical purposes as therapy adjuvant for patients with. European Journal of Clinical Nutrition 2007 61 7 906 915 2-s2.0-34447252549 10.1038/sj.ejcn.1602571 (Pubitemid 47040315)
89. Wood A., Baxter G., Thies F., Kyle J., Duthie G., A systematic review of salicylates in foods: estimated daily intake of a Scottish population. Molecular Nutrition and Food Research 2011 55 supplement 1 S7 S14 2-s2.0-79957876276 10.1002/mnfr.201000408
90. Wang C., Zhao J., Chen F., Cheng Y., Guo A., Separation, identification, and quantitation of phenolic acids in Chinese Waxberry (Myrica Rubra) Juice by HPLC-PDA-ESI-MS. Journal of Food Science 2012 77 2 C272 C277 2-s2.0-84857139666 10.1111/j.1750-3841.2011.02563.x
91. Perarnau J.-M., Bacq Y., Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy. Seminars in Liver Disease 2008 28 3 315 327 2-s2.0-52949087176 10.1055/s-0028-1085099
92. Van Der Loo B., Labugger R., Aebischer C. P., Bachschmid M., Spitzer V., Kilo J., Altwegg L., Ullrich V., Lüscher T. F., Age-related changes of vitamin A status. Journal of Cardiovascular Pharmacology 2004 43 1 26 30 2-s2.0-0348223827 10.1097/00005344-200401000-00005 (Pubitemid 38032060)
93. Delcò F., Tchambaz L., Schlienger R., Drewe J., Krähenbühl S., Dose adjustment in patients with liver disease. Drug Safety 2005 28 6 529 545 (Pubitemid 41003057)
94. Zhang J., Two characteristics on the developmental history of art of prescription. Zhonghua Yi Shi Za Zhi 2002 32 3 135 139 2-s2.0-0036666442
95. Ryan M., Desmond P., Liver toxicity. Could this be a drug reaction? Australian Family Physician 2001 30 5 427 431 2-s2.0-0035346325
96. Konings E. J. M., Water-soluble vitamins. Journal of AOAC International 2006 89 1 285 288 2-s2.0-33646862820
97. Ratamess N. A., Hoffman J. R., Ross R., Shanklin M., Faigenbaum A. D., Kang J., Effects of an amino acid/creatine energy supplement on the acute hormonal response to resistance exercise. International Journal of Sport Nutrition and Exercise Metabolism 2007 17 6 608 623 2-s2.0-37549037835
98. Gudkov S. V., Gudkova O. Y., Chernikov A. V., Bruskov V. I., Protection of mice against X-ray injuries by the post-irradiation administration of guanosine and inosine. International Journal of Radiation Biology 2009 85 2 116 125 2-s2.0-65649124554 10.1080/09553000802641144
99. Cui J.-H., Cao Q.-R., Lee B.-J., Enhanced delivery of bifidobacteria and fecal changes after multiple oral administrations of bifidobacteria-loaded alginate poly-l-lysine microparticles in human volunteers. Drug Delivery 2007 14 5 265 271 2-s2.0-34347379903 10.1080/10717540601067844 (Pubitemid 47027037)
100. Rodríguez-Fragoso L., Martínez-Arismendi J. L., Orozco-Bustos D., Reyes-Esparza J., Torres E., Burchiel S. W., Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters. Journal of Food Science 2011 76 4 R112 R124 2-s2.0-79955593489 10.1111/j.1750-3841.2011.02155.x
101. Charbon G. A., Anderson M. F., Hepatic haemodynamics as related to blood flow through gut, spleen, and pancreas. Gut 1989 30 2 265 278 2-s2.0-0024602377 (Pubitemid 19058882)
102. Daneshmend T. K., Jackson L., Roberts C. J. C., Physiological and pharmacological variability in estimated hepatic blood flow in man. British Journal of Clinical Pharmacology 1981 11 5 491 496 2-s2.0-0019505157 (Pubitemid 11150190)
103. Qi Y. Y., Xiao L., Zhang L. D., Tanshinone IIA pretreatment attenuates hepatic ischemia-reperfusion. Frontiers in Bioscience (Elite Edition) 2012 4 1303 1313
104. Bi C. W. C., Xu L., Zhang W. L., Zhan J. Y. X., Fu Q., Zheng K. Y. Z., Chen V. P., Lau D. T. W., Choi R. C. Y., Wang T. J., Dong T. T. X., Tsim K. W. K., Fo Shou San, an ancient herbal decoction prepared from Angelicae Sinensis Radix and Chuanxiong Rhizoma, induces erythropoietin expression: a signaling mediated by the reduced degradation of hypoxia-inducible factor in cultured liver cells. Planta Medica 2012 78 2 122 127 2-s2.0-84856242445 10.1055/s-0031-1280356
105. Biesalski H. K., Meat and cancer: meat as a component of a healthy diet. European Journal of Clinical Nutrition 2002 56 supplement 1 S2 S11 2-s2.0-0036231170 10.1038/sj/ejcn/1601347 (Pubitemid 34413832)
106. Freedman N. D., Cross A. J., McGlynn K. A., Abnet C. C., Park Y., Hollenbeck A. R., Schatzkin A., Everhart J. E., Sinha R., Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. Journal of the National Cancer Institute 2010 102 17 1354 1365 2-s2.0-77956568460 10.1093/jnci/djq301
107. Nevens F., Colle I., Michielsen P., Resource use and cost of hepatitis C-related care. European Journal of Gastroenterology and Hepatology 2012 24 10 1191 1198
108. Kwon H., Lee S.-H., Kim S.-E., Lee J.-H., Jee Y.-K., Kang H.-R., Park B.-J., Park J.-W., Hong C.-S., Spontaneously reported hepatic adverse drug events in Korea: multicenter study. Journal of Korean Medical Science 2012 27 3 268 273 2-s2.0-84858068879 10.3346/jkms.2012.27.3.268
109. Yamaza H., Komatsu T., To K., Toyama H., Chiba T., Higami Y., Shimokawa I., Involvement of insulin-like growth factor-1 in the effect of caloric restriction: regulation of plasma adiponectin and leptin. Journals of Gerontology 2007 62 1 27 33 2-s2.0-34047113944 (Pubitemid 46931543)
110. Ye Y. N., Liu E. S. L., Li Y., So H. L., Cho C. C. M., Sheng H. P., Lee S. S., Cho C. H., Protective effect of polysaccharides-enriched fraction from Angelica sinensis on hepatic injury. Life Sciences 2001 69 6 637 646 2-s2.0-0035967847 10.1016/S0024-3205(01)01153-5 (Pubitemid 32673622)
111. Lodha R., Bagga A., Traditional Indian systems of medicine. Annals of the Academy of Medicine Singapore 2000 29 1 37 41 2-s2.0-0034117911 (Pubitemid 30252144)
112. Cefalu W. T., Ye J., Wang Z. Q., Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. Endocrine, Metabolic and Immune Disorders 2008 8 2 78 81 2-s2.0-47249156463 10.2174/187153008784534376
113. Popovich D. G., Yeo S. Y., Zhang W., Ginseng (Panax quinquefolius) and licorice (Glycyrrhiza uralensis) root extract combinations increase hepatocarcinoma cell (Hep-G2) viability. Evidence-Based Complementary and Alternative Medicine 2011 2011 9 2-s2.0-79959201798 10.1093/ecam/nep074 408273
114. Wang X., Zhang A., Wang P., Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies. Molecular & Cell Proteomics 2013 12 5 1226 1238
115. De Cruz S., Espiritu J. R. D., Zeidler M., Wang T. S., Sleep disorders in chronic liver disease. Seminars in Respiratory and Critical Care Medicine 2012 33 1 26 35 2-s2.0-84858714115 10.1055/s-0032-1301732